Publications

Published

  57100: Phase II Trial of Induction Gemcitabine/CPT-11 Followed by Twice-Weekly Infusion Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer  (Am J Clin Oncol 2005;28: 345–350) 

57198: Phase II Trial of Adjuvant (2’2’-Defluoro-2’-Deoxycytidine) Gemcitabine and External Beam Radiation for the Treatment of Resectable Pancreatic Cancer  (Oncology 2002;16(Suppl. 5):25-28) 

57198: Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study.  (British Journal of Cancer 2006;95:260-265)

60A02: Phase II randomized placebo-controlled double-blind chemoprevention trial of fruit/vegetable concentrates on intermediate biomarkers in head/neck cancer. (J Clin Oncol 28:15s, 2010 (suppl; abstr 1521))

60A02: Stress and depression in head and neck cancer patients by primary surgery versus primary radiotherapy treatment modality. (J Clin Oncol 28:15s, 2010 (suppl; abstr 5597))

62300: Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer. (Lung Cancer 2006;54:379-385.)

62400: Phase II Study of Carboplatin, Irinotecan, and Thalidomide in Patients with Advanced Non-Small Cell Lung Cancer.  (Journal of Thoracic Oncology 2006; 1:832-836.)

91105: Correlation of cognitive symptoms with cognitive performance among brain cancer patients after radiation therapy. (J Clin Oncol 28:15s, 2010 (suppl; abstr 2084))

91105: Quality of life (QOL) and cognitive performance among irradiated brain cancer patients. (J Clin Oncol 28:15s, 2010 (suppl; abstr 9131))

91105: Phase III randomized double blind placebo controlled trial of donepezil in irradiated brain tumor survivors. (ASCO submission, Chicago, IL 2013)

91105: Quality of life and cognitive status among irradiated brain tumor survivors treated with donepezil or placebo. (ASCO submission, Chicago, IL 2013)

91105: MRI markers of neurocognitive ability in human cancer survivors following brain irradiation therapy. (Neuroscience abract,  2010)

91105: Normal Tissue Complication Modeling of the Brain: Dose-volume Histogram Analysis of Neurogconitive Outcomes of Two CCOP Trials (ASTRO absract, 2011)

91105: Normal Tissue Complication Modeling of the Brain: Dose-volume Histogram Analysis of Neurogconitive Outcomes of Two CCOP Trials (Neuro-Oncology, 2011)

91105: Magnetic Resonance Imaging Associates with Differences in Neurocognitive Performance for Cancer Survivors Complaining of Cognitive Deficits Following Brain Irradiation (Neuro-Oncology, 2012)

91105: Neuroanatomical target therory as a predictive model for radiation-induced cognitive decline (Neurology 2013)

91202: A phase II trial of thalidomide (Thal) and procarbazine (Pro) in adults with recurrent or progressive malignant gliomas (MG)  (J Clin Oncol 2007;25:2067)

91202:A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas(Journal of Neuro-Oncology: Volume 106, Issue 3 (2012), Page 611-617) 

97100: Phase II Studies of Donepezil and Ginkgo Biloba in Irradiated Brain Tumor Patients  (J Clin Oncol 2006;24:1415-1420)

97100: Patient Reported Outcomes in Phase II Cancer Clinical Trials: Lessons Learned and Future Directions (J Clin Oncol 2007;25:000-000)

97100: Phase II study of ginkgo biloba in irradiated brain tumor survivors: Effects on quality of life (QOL), mood, and cognitive function.(J Clin Oncol 28, 2010 (suppl; abstr e12523))

97100: Neuroanatomical target theory as a predictive model for radiation induced cognitive decline (Neurology 80:747-753, 2013)

97100: Phase II study of ginkgo biloba in irradiated brain tumor patients: Effects on cognitive function, quality of life, and mood (J Neuro-Oncolo 109:357-363, 2012)

97100: Integrating Patient-Reported Outcomes Into Cancer Symptom Management Clinical Trials Supported by the National Cancer Institute–Sponsored Clinical Trials Networks (J Clin Onclo 2007;25:5070-5077)

97102:A phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on lean body mass (LBM), weight (wt) and quality of life (QOL) in patients with solid tumors and weight loss receiving chemotherapy. (Proc Am Soc Clin Onc, 26(15S):505s, 2008)

97106: Does L-arginine/Korean ginseng/gingko biloba/damiana-based supplement improve the sexual function and quality of life of female cancer srviviors: A randomized trial. (J Clin Oncol 29: 2011 (suppl; abstr 9016))

97202:Self-reported compliance compared to biomarker levels of vitamin E in breast cancer patients participating in a CoQ10 clinical trial.(J Clin Oncol 28, 2010 (suppl; abstr e19524))

97202: A randomized double-blind placebo-controlled study of oral coenzyme Q10 to relieve self-reported cancer-treatment-related fatigue in newly diagnosed breast cancer patients. (J Clin Oncol 28:15s, 2010 (suppl; abstr 9006))

97202: Coenzyme Q10.  (Oncology Nurse Edition  2011 Oct;25(10 Suppl Nurse Ed):36-40.)

97202: A randomized double-blind placebo-controlled study of oral coenzyme Q10 to relieve self-reported cancer-treatment-related fatigue in newly diagnosed breast cancer patients. (Supportive Oncology, in press)

97202: Comparing three validated methods of patient self-reported fatigue in a prospective randomized clinical trial (ASCO Poster presentation, Chicago, IL 2012)

97300: A Phase III, Double-Blind, Randomized Study of the Effect of Megestrol Acetate on Weight and Health Related Quality of Life in Head and Neck Cancer Patients Receiving  Radiation Therapy(Int J Radiation Oncology Biol Phys 2002;52:1180–1185)

97301: Results of Diet/Exercise Feasibility Trial to Prevent Adverse Body Composition Change in Breast Cancer Patients on Adjuvant Chemotherapy
(Clinical Breast Cancer 2008;8:70-79)

97309:Feasibility of a Multisite, Community-based Randomizzed Study of Yoga and Wellness Education for Women With Breast Cancer Undergoing Chemotherapy (International Journal of Yoga Therapy No. 23, 2013)​

97405: A Phase II randomized, double-blind, placebo-controlled trail of soy protein and venlafaxine for treatment of hot flashes in men with prostate cancer. (J Clin Oncol 29: 2011 (suppl; abstr 9027)

97405: Randomized Trial to Assess the Impact of Venlafaxine and Soy Protein on Hot Flashes and Quality of Life in Men with Prostate Cancer. (J Clin Oncol 31:32)

97509: A Phase II double-blind placebo-controlled study of armodafinil for brain radiation induced fatigue. J Clin Oncol 2013 (suppl; abstr 9505)

97600: A Phase III, Double-Blind, Placebo-Controlled Prospective Randomized Clinical Trial Of D-Threo-Methylphenidate Hcl In Brain Tumor Patients Receiving Radiation Therapy
(Int. J. Radiation Oncology Biol. Phys., 2007;69:1496–1501)

97600: Symptom Clusters in Patients With Newly-Diagnosed Brain Tumors  (J Support Oncol 2007;5:427–433, 436)

97609:  Minority accrual on a prospective study targeting a diverse US breast cancer population: An analysis of Wake Forest CCOP research base protocol 97609 (J Clin Oncolo, 2013 ASCO Meeting Absract 31:15)

98301: A Phase II Pilot of St. John’s Wort for the Treatment of Hot Flushes in Women with a History of Breast Cancer. (J Clin Oncol 29: 2011 (suppl;  abstr e19685) 

98308:Monitoring Clinical Trial Accrual Utilizing The NCCCP  Web Based Tracking Tool (ASCO Proceedings, in press, 2009)

98308: A phase III randomized, double-blind, placebo controlled trial of North American (NA) ginseng (Panax quinquefolium) extract (CVT-E002) in patients with chronic lymphocytic leukemia: Effect on respiratory infection and antibiotic use. (J Clin Oncol 28:15s, 2010 (suppl; abstr 6578)) 

98308: A Randomized, Controlled Trial of Panax quinquefolius Extract (CVT-E002) to Reduce Respiratory Infection in Patients With Chronic Lymphocytic Leukemia. (J Support Oncol. 2012 Jan 20)    

Recruitment and retention in the Wake Forest University CCOP Research Base. (J Clin Oncol 28, 2010 (suppl; abstr e19543))

Quick Reference

Research Base

Fax 336-716-6275
Phone 336-716-0891

2000 West First Street
Protocol Information Office
Suite 101
Winston-Salem, NC 27104
Find A Doctor Ways to Give
Last Updated: 12-01-2014
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.